The discount-store operator on Monday guided for comparable sales—or those from stores and digital channels open for at least a year—to rise 3% to 4% in 2026, a slowdown from the 5.3% gain the company ...

Sylogist (TSE:SYZ) executives used the company’s fiscal fourth-quarter 2025 earnings call to emphasize progress in its multi-year shift from legacy software and one-time services work toward a more ...

Knight Therapeutics (TSE:GUD) reported record fourth-quarter and full-year 2025 financial results on its March 19, 2026 earnings call, highlighting strong revenue growth, expanding contributions from ...